Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
Clinical trial NCT01985009 · COMPLETED
Trial details
- NCT number
- NCT01985009
- Sponsor
- Echosens
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2017-01-17
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.